CHICAGO, March 21, 2017 -- As previously announced, members of Allscripts (NASDAQ:MDRX) management team are hosting an Investor Day for the financial community today, March 21, 2017, in New York City. The event is scheduled to begin at 8:00 a.m. ET and will conclude at 1:30 p.m. ET.
Allscripts leadership team will present financial information and an overview of the company's strategic vision and growth strategy for domestic core systems, global markets, value-based care and post-acute segments.
The event will be live webcasted and presentation materials will be available at Allscripts investor relations website.
About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2017 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact: Investors: Seth Frank 312-506-1213 [email protected] Media: Concetta Rasiarmos 312-447-2466 [email protected]


Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds
xAI Cash Burn Highlights the High Cost of Competing in Generative AI
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable”
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 



